Business
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning
NEW YORK, NY / ACCESS Newswire / March 25, 2026 / New to The Street, a premier financial media platform known for its national television distribution and integrated investor engagement strategy, today announced a strategic 12-part media partnership ...
About this update from Igc Pharma, Inc.
[{"type":"text","content":"NEW YORK, NY / ACCESS Newswire / March 25, 2026 / New to The Street, a premier financial media platform known for its national television distribution and integrated investor engagement strategy, today announced a strategic 12-part media partnership with IGC Pharma, Inc. (NYSE American:IGC), a clinical-stage biotechnology company leveraging artificial intelligence to develop treatments for Alzheimer's disease and metabolic disorders.","length":441,"tagName":"p"},{"type":"text","content":"The multi-faceted campaign is designed to elevate IGC Pharma's visibility across institutional and retail investor audiences through a coordinated media strategy that includes long-form television interviews, national TV commercial distribution, high-impact outdoor billboard placements, and curated accredited investor events in key financial markets.","length":356,"tagName":"p"},{"type":"text","content":"Through this initiative, IGC Pharma will be featured across New to The Street's sponsored programming on Fox Business and Bloomberg Television, alongside amplification to a combined digital audience exceeding 4.45 million YouTube subscribers. The campaign will also include dominant outdoor placements in Times Square and the New York City Financial District, as well as earned media distribution across major U.S. broadcast affiliates.","length":440,"tagName":"p"},{"type":"text","content":""This partnership represents a strategic step forward in expanding our visibility within the global investment community," said Ram Mukunda, CEO of IGC Pharma. "New to The Street's unmatched ability to combine television, digital distribution, and outdoor media provides us with a powerful platform to communicate our clinical progress, including our Phase 2 CALMA trial, and to position IGC Pharma at the forefront of AI-driven biopharmaceutical innovation."","length":483,"tagName":"p"},{"type":"text","content":""We are proud to launch this 12-part series with IGC Pharma at a time when Alzheimer's continues to impact millions of families across the United States and around the world," said Vince Caruso, co-founder and CEO of New to The Street. "This is about more than visibility - it's about bringing forward companies that are working on real solutions. IGC Pharma is advancing meaningful progress in an area ...